Bioavailability of the Microconstituents of Natural Chios Mastiha in Healthy Adults.
Launched by HAROKOPIO UNIVERSITY · Jul 27, 2016
Trial Information
Current as of May 12, 2025
Completed
Keywords
ClinConnect Summary
No description provided
Gender
MALE
Eligibility criteria
- Inclusion Criteria:
- • Age: 20-40 years old
- • BMI: 18.5-24.9 kg/m2
- Exclusion Criteria:
- • BMI \> 25 kg/m2
- • Alcohol or drug abuse
- • Medication, vitamin or inorganic supplements
- • Vegan or macrobiotic diet before and during the study
- • Gastrointestinal diseases, such as IBD, peptic ulcer or GI cancer
About Harokopio University
Harokopio University, located in Athens, Greece, is a prominent academic institution dedicated to advancing research and education in various fields, including health sciences and nutrition. With a strong commitment to interdisciplinary collaboration, the university actively engages in clinical trials aimed at exploring innovative solutions to pressing health challenges. Through its rigorous research programs and partnerships with healthcare professionals, Harokopio University strives to contribute valuable insights to the scientific community and improve public health outcomes.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Athens, , Greece
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials